Anna Bershteyn
Anna Bershteyn
New York University School of Medicine
Verified email at
Cited by
Cited by
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
MT Stephan, JJ Moon, SH Um, A Bershteyn, DJ Irvine
Nature medicine 16 (9), 1035-1041, 2010
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
JJ Moon, H Suh, A Bershteyn, MT Stephan, H Liu, B Huang, M Sohail, ...
Nature materials 10 (3), 243-251, 2011
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa
JW Eaton, LF Johnson, JA Salomon, T Bärnighausen, E Bendavid, ...
PLoS medicine 9 (7), e1001245, 2012
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models
BL Jewell, E Mudimu, J Stover, D Ten Brink, AN Phillips, JA Smith, ...
The lancet HIV 7 (9), e629-e640, 2020
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
Bioactive hydrogels with an ordered cellular structure combine interconnected macroporosity and robust mechanical properties
AN Stachowiak, A Bershteyn, E Tzatzalos, DJ Irvine
Advanced Materials 17 (4), 399-403, 2005
Sustainable HIV treatment in Africa through viral-load-informed differentiated care
A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ...
Nature 528 (7580), S68-S76, 2015
Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
AR Kirtane, O Abouzid, D Minahan, T Bensel, AL Hill, C Selinger, ...
Nature communications 9 (1), 1-12, 2018
Polymer-supported lipid shells, onions, and flowers
A Bershteyn, J Chaparro, R Yau, M Kim, E Reinherz, L Ferreira-Moita, ...
Soft matter 4 (9), 1787-1791, 2008
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine
A Bershteyn, MC Hanson, MP Crespo, JJ Moon, AV Li, H Suh, DJ Irvine
Journal of controlled release 157 (3), 354-365, 2012
Hydroxychloroquine as postexposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 infection: a randomized trial
RV Barnabas, ER Brown, A Bershteyn, HC Stankiewicz Karita, ...
Annals of internal medicine 174 (3), 344-352, 2021
Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized …
MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ...
Jama 327 (5), 432-441, 2022
Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial
RV Barnabas, AA Szpiro, H van Rooyen, S Asiimwe, D Pillay, NC Ware, ...
The lancet Global health 8 (10), e1305-e1315, 2020
Point-of-care HIV viral load testing: an essential tool for a sustainable global HIV/AIDS response
PK Drain, J Dorward, A Bender, L Lillis, F Marinucci, J Sacks, A Bershteyn, ...
Clinical microbiology reviews 32 (3), 10.1128/cmr. 00097-18, 2019
HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
PLoS Medicine 9 (7), e1001259, 2012
Sexual partnership age pairings and risk of HIV acquisition in rural South Africa
A Akullian, A Bershteyn, D Klein, A Vandormael, T Bärnighausen, ...
Aids 31 (12), 1755-1764, 2017
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: a randomized clinical trial
C Johnston, ER Brown, J Stewart, HCS Karita, PJ Kissinger, J Dwyer, ...
EClinicalMedicine 33, 2021
Nanobiomechanics of repair bone regenerated by genetically modified mesenchymal stem cells
K Tai, G Pelled, D Sheyn, A Bershteyn, L Han, I Kallai, Y Zilberman, ...
Tissue Engineering Part A 14 (10), 1709-1720, 2008
Implementation and applications of EMOD, an individual-based multi-disease modeling platform
A Bershteyn, J Gerardin, D Bridenbecker, CW Lorton, J Bloedow, ...
Pathogens and disease 76 (5), fty059, 2018
Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral …
JW Eaton, N Bacaër, A Bershteyn, V Cambiano, A Cori, RE Dorrington, ...
The Lancet Global Health 3 (10), e598-e608, 2015
The system can't perform the operation now. Try again later.
Articles 1–20